Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

NCT00000838 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

256

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lamivudine
DRUG: Stavudine
DRUG: Zidovudine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)